Huaxia Eye Hospital Group Co. Ltd. A (SHE:301267) — Market Cap & Net Worth
Market Cap & Net Worth: Huaxia Eye Hospital Group Co. Ltd. A (301267)
Huaxia Eye Hospital Group Co. Ltd. A (SHE:301267) has a market capitalization of $2.24 Billion (CN¥15.28 Billion) as of May 3, 2026. Listed on the SHE stock exchange, this China-based company holds position #5861 globally and #1241 in its home market, demonstrating a 4.96% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Huaxia Eye Hospital Group Co. Ltd. A's stock price CN¥18.19 by its total outstanding shares 840000000 (840.00 Million). Analyse Huaxia Eye Hospital Group Co. Ltd. A (301267) cash conversion ratio to see how efficiently the company converts income to cash.
Huaxia Eye Hospital Group Co. Ltd. A Market Cap History: 2022 to 2026
Huaxia Eye Hospital Group Co. Ltd. A's market capitalization history from 2022 to 2026. Data shows change from $5.92 Billion to $2.24 Billion (-23.47% CAGR).
Index Memberships
Huaxia Eye Hospital Group Co. Ltd. A is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ChiNext
CNT
|
$1.31 Trillion | 0.17% | #87 of 100 |
Weight: Huaxia Eye Hospital Group Co. Ltd. A's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Huaxia Eye Hospital Group Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Huaxia Eye Hospital Group Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.58x
Huaxia Eye Hospital Group Co. Ltd. A's market cap is 0.58 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.46x
Huaxia Eye Hospital Group Co. Ltd. A's market cap is 5.46 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $5.92 Billion | $3.23 Billion | $513.82 Million | 1.83x | 11.51x |
| 2023 | $3.92 Billion | $4.01 Billion | $665.93 Million | 0.98x | 5.89x |
| 2024 | $2.34 Billion | $4.03 Billion | $428.64 Million | 0.58x | 5.46x |
Competitor Companies of 301267 by Market Capitalization
Companies near Huaxia Eye Hospital Group Co. Ltd. A in the global market cap rankings as of May 3, 2026.
Key companies related to Huaxia Eye Hospital Group Co. Ltd. A by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #256 globally with a market cap of $96.85 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #962 globally with a market cap of $27.16 Billion USD ( €23.23 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #972 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1292 globally with a market cap of $19.57 Billion USD ( RM77.93 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #256 | HCA Holdings Inc | NYSE:HCA | $96.85 Billion | $433.09 |
| #962 | Fresenius SE & Co. KGaA | XETRA:FRE | $27.16 Billion | €41.25 |
| #972 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1292 | IHH Healthcare Bhd | KLSE:5225 | $19.57 Billion | RM8.82 |
Huaxia Eye Hospital Group Co. Ltd. A Historical Marketcap From 2022 to 2026
Between 2022 and today, Huaxia Eye Hospital Group Co. Ltd. A's market cap moved from $5.92 Billion to $ 2.24 Billion, with a yearly change of -23.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.24 Billion | +1.17% |
| 2025 | CN¥2.21 Billion | -5.57% |
| 2024 | CN¥2.34 Billion | -40.35% |
| 2023 | CN¥3.92 Billion | -33.68% |
| 2022 | CN¥5.92 Billion | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Huaxia Eye Hospital Group Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.24 Billion USD |
| MoneyControl | $2.24 Billion USD |
| MarketWatch | $2.24 Billion USD |
| marketcap.company | $2.24 Billion USD |
| Reuters | $2.24 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Huaxia Eye Hospital Group Co. Ltd. A
Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally. The company provides general ophthalmology diagnosis and treatment services for patients with ophthalmic diseases; and myopia prevention and intervention work to the public. It offers services in the areas of cataract, refraction, fundus, strabismus and amblyopia, pediatric ophthalmology, ocular … Read more